MONITORING LIVER-TUMOR THERAPY WITH [F-18] FDG POSITRON EMISSION TOMOGRAPHY
- 1 May 1990
- journal article
- research article
- Vol. 14 (3) , 370-374
Abstract
Positron emission tomography (PET) with [18F]-2-fluorodeoxyglucose (FDG) can be utilized as a functional imaging modality for monitoring liver tumor therapy. We report three cases in which PET-FDG was more useful for this purpose than other imaging methods and tumor markers.This publication has 4 references indexed in Scilit:
- Performance Characteristics of Positologica IIIJournal of Computer Assisted Tomography, 1985
- Hepatocellular carcinoma treated by transcatheter arterial embolization: progress evaluated by computed tomography.Radiology, 1984
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977
- COMPARATIVE BIOCHEMISTRY OF HEPATOMAS .2. ISOTOPE STUDIES OF CARBOHYDRATE METABOLISM IN MORRIS HEPATOMA 51231961